Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

James M. Mock

At a glance: James M. Mock is CFO at Moderna (MRNA). Their latest SEC Form 4, filed Sep 14, 2026, reported a sale of $2.7M. On file: 0 purchase lines ($0) and 2 sale lines ($4.7M).

Disclosed holdings: about $11.9M of MRNA stock: 59,375 shares reported on their latest Form 4 (filed Sep 14, 2026), valued at the Nov 19, 2026 close of $200.20. This counts only MRNA shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CFO at Moderna, Inc. (MRNA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.7M

James M. Mock's InsiderPrint

2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of James M. Mock: 2 trades, 2026 to 20262026: 0 buys, 2 sales
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Sep 14SEC MRNAModerna, Inc. Sell Plan 19,83674,375 held (−21%) $134.49 $2.7M +48.9%
Sep 14SEC MRNAModerna, Inc. Sell Plan 15,00059,375 held (−20%) $134.49 $2.0M +48.9%
  • Sell

    CFO James M Mock sold $2.7M of MRNA at $134.49 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO James M Mock sold $2.0M of MRNA at $134.49 — pre-scheduled 10b5-1 plan sale.

Follow James M. Mock

Get one email when James M. Mock files a new purchase or sale. Free.

At most one email a day about James M. Mock, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.